Kendle Reports 78% Drop in Profits, Begins Cost-Saving Efforts

Thursday, May 7, 2009 07:00 AM

Cincinnati-based contract research organization (CRO) Kendle warned investors earlier this month that first quarter 2009 profits would be down, and down they are.

The company reported net income of $886,000 or $0.06 per share for the first quarter 2009, compared with net income of $4.1 million or $0.27 per diluted share for the same period last year. Net service revenues for the quarter totaled $108.1 million, compared with $1.14 million in the first quarter 2008.

Kendle chairman and CEO Candace Kendle warned shareholders earlier this month that first quarter revenues would be significantly lower than original forecasts. That news caused the company’s shares to plummet more than 50%. Following the company’s earnings release yesterday, Kendle’s share price increased in after-hours trading by half a percentage point to $9.61.

To cut costs, Kendle has implemented strict controls over discretionary spending, a hiring and wage freeze and “workforce optimization initiatives.”  The company said it plans to reorganize its leadership structure, ultimately saving between $17.5 million and $22.5 million in the second half of 2009.

“We are taking aggressive steps to enhance our business development efforts, realign our leadership and organizational structure and implement a series of margin improvement and cost reduction initiatives to move our business to the next level,” Kendle said in a company statement.

Senior vice president and chief financial officer (CFO) and secretary Karl “Buzz” Brenkert III abruptly left the CRO last week, after six years as CFO. He was replaced by Kendle’s vice president of accounting Keith Cheesman.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs